Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old, of any sex, who are right-handed and have a resting heart rate between 60 and 100 beats per minute.
- People with a confirmed diagnosis of coronary heart disease (CHD), meaning at least one of the following applies: an abnormal stress test result; a documented heart attack confirmed by heart tracing (ECG) changes and specific blood markers; or a scan showing a blockage of 50% or more in at least one heart artery.
- People who have been diagnosed with an anxiety disorder according to current standard psychiatric guidelines (DSM-5).
- People whose anxiety symptoms score at 16 or above on a standard anxiety rating scale (HAMA), and whose depression symptoms score at 17 or below on a standard depression rating scale (HAMD-17).
Who may not be able to join:
- People currently experiencing acute unstable chest pain (unstable angina).
- People with severe heart failure classified as the most advanced stage (NYHA Class IV).
- People with a heart valve condition.
- People with a history of atrial fibrillation (an irregular heart rhythm condition).
- People with unstable blood pressure, meaning a systolic reading above 180 mmHg or below 90 mmHg.
- People who are pregnant.
- People with a history of certain unstable medical conditions, including stroke-related brain disease, dementia, an overactive thyroid, lung disease, or cancer (confirm with trial site for how these are assessed).
- People considered to be at high risk of suicide or harm to others.
- People with other psychiatric conditions, including psychotic disorders, bipolar disorder, or an active substance use disorder.
- People who have taken psychiatric or mood-affecting medications within the one month before enrolling in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yun-En Liu, MD, Shenyang Medical College
Phone: 86-24-62215130
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The between-group difference (real neurofeedback vs sham) in baseline-corrected heart rate (HR) during the task stimulation window.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.